FDA NDC Directory · JSON-LD · Markdown

Fiasp

NDC 0169-3206 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameinsulin aspart
Labeler / ManufacturerNovo Nordisk
Marketing categoryBiologic License Application · App BLA208751
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsINSULIN ASPART (100 [iU]/mL)
Marketing started20171020
Package count2

External sources

Source: openFDA. Public-domain (CC0).